Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

Table 1

Clinicopathological characteristics of FUSCC PDAC patients stratified by MUC1 expression.

Variables	MUC1 negative	MUC1 positive
Age, (%)			0.303
<62	19 (55.9%)	183 (46.7%)
≥62	15 (44.1%)	209 (53.3%)
Sex, (%)			0.110
Male	24 (70.6%)	218 (56.5%)
Female	10 (29.4%)	168 (43.5%)
Tumour grade, (%)			0.534
Low	2 (5.9%)	17 (4.4%)
Moderate	23 (67.6%)	230 (59.7%)
High	9 (26.5%)	138 (35.8%)
Tumour stage, (%)			0.011
I	15 (44.1%)	154 (39.3%)
II	10 (29.4%)	195 (49.7%)
III	9 (26.5%)	43 (11.0%)
T stage, (%)			0.591
T1	8 (23.5%)	67 (17.1%)
T2	19 (55.9%)	225 (57.4%)
T3	7 (20.6%)	100 (25.5%)
N stage, (%)			0.499
N0	19 (55.9%)	197 (51.0%)
N1	10 (29.4%)	149 (38.6%)
N2	5 (14.7%)	40 (10.4%)
Tumour location, (%)			0.222
Head	20 (58.8%)	210 (54.4%)
Body	13 (38.2%)	174 (45.1%)
Tail	1 (2.9%)	2 (0.5%)
Vascular invasion, (%)			0.681
No	10 (29.4%)	101 (26.2%)
Yes	24 (70.6%)	285 (73.8%)
Perineural infiltration, (%)			0.011
No	25 (73.5%)	342 (88.6%)
Yes	9 (26.5%)	44 (11.4%)
Diabetes mellitus, (%)			0.226
No	26 (76.5%)	326 (84.5%)
Yes	8 (23.5%)	60 (15.5%)